Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

7.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.4K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NSAID use is associated with lower dementia and Alzheimer's disease prevalence and slower cognitive decline: A retrospective longitudinal analysis of the NACC cohort.

medRxiv : the preprint server for health sciences·2026
Same author

The delayed morbidity of war.

Journal of the Royal Society of Medicine·2026
Same author

Seeing the unseen in multiple sclerosis: From reactive care to anticipatory medicine.

Journal of the neurological sciences·2026
Same author

Precision medicine without equity is just stratified inequality.

Nature·2026
Same author

Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Optimising pandemic response through vaccination strategies using neural networks.

Scientific reports·2026

Related Experiment Video

Updated: Sep 7, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K

Clinical trials in multiple sclerosis: past, present, and future.

Navid Manouchehri1, Afsaneh Shirani2, Victor H Salinas1

  • 1Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, United States.

Neurologia I Neurochirurgia Polska
|June 17, 2022
PubMed
Summary

Multiple sclerosis (MS) clinical trials have advanced significantly, leading to effective disease-modifying therapies (DMTs). Continued progress in diagnostics and biomarkers offers a roadmap for future MS interventions.

Keywords:
clinical trialsmultiple sclerosispharmacology

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.8K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K

Related Experiment Videos

Last Updated: Sep 7, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.2K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

4.8K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.6K

Area of Science:

  • Neuroimmunology
  • Clinical Trials
  • Neuroscience

Background:

  • Multiple sclerosis (MS) has been a major focus for clinical trial development over the past 40 years.
  • Advances in neuroimmunology have yielded effective disease-modifying therapies (DMTs) for MS patients.
  • Progress in diagnostic criteria, disability assessment, imaging, and biomarkers has enhanced MS management.

Purpose of the Study:

  • To review the evolution of clinical trials in multiple sclerosis.
  • To discuss the achievements in MS treatment and management.
  • To identify opportunities for future improvements in MS clinical trials.

Main Methods:

  • Review of historical clinical trial data in multiple sclerosis.
  • Analysis of advancements in neuroimmunology and therapeutic development.
  • Examination of diagnostic and assessment tools in MS.

Main Results:

  • Significant progress in developing disease-modifying therapies (DMTs) for MS.
  • Enhanced understanding of MS pathophysiology.
  • Established clinical practices for MS diagnosis and management.

Conclusions:

  • The evolution of MS clinical trials has led to substantial patient benefits.
  • Current knowledge and practices provide a foundation for developing more targeted MS interventions.
  • Opportunities exist to further refine MS clinical trials for improved outcomes.